Research News
Published in:
Volume 12 / Year 2023 / Issue 3
Volume 12 / Year 2023 / Issue 3
Infliximab discontinuation in patients with originator retransition vs biosimilar continuation
Page: 107
Submitted: 4 November 2023; Revised: 24 November 2023; Accepted: 27 November 2023; Published online first: 28 November 2023 A study by Meijboom et al. aimed to compare the risk of and… Read More »
Switches between biosimilars and their reference products
Author(s): Sarah Schrieber, PharmD
Page: 106
Page: 106
Submitted: 22 November 2023; Revised: 24 November 2023; Accepted: 27 November 2023; Published online first: 28 November 2023 Biologicals are the fastest-growing class of medications in the United States and account… Read More »